Certican 0.25mg Tablet: Effective Immunosuppressant for Medical Use

Certican 0.25mg Tablet

Uses:

• Advanced breast cancer
• Advanced renal cell carcinoma
• Advanced pancreatic neuroendocrine tumours
• Treatment of subependymal giant cell astrocytoma

Therapeutic Effects:

• Inhibits the activity of mammalian target of rapamycin (mTOR), which regulates cell growth
• Slows the growth of abnormal cancer cells by blocking the mTOR protein
• Helps to reduce the size of tumours and improve outcomes in patients

Interaction with Other Drugs:

• Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products
• Certain medications may interact with Certican 0.25mg tablet and reduce effectiveness by causing undesirable side effects

Safety Advices:

• Pregnancy: not recommended for pregnant women as it may cause fetal harm
• Breastfeeding: passes into breast milk and harms the baby
• Lungs: consult your doctor if you have any lung diseases before starting the treatment
• Liver: inform your doctor if you have any liver problems before taking Certican 0.25mg tablet
• Alcohol: consuming alcohol may affect the effectiveness of Certican 0.25mg tablet
• Driving: it is unsafe to drive vehicles or operate heavy machinery after taking Certican 0.25mg tablet, it may cause dizziness and impair your concentration

Side Effects:

• Serious: difficulty breathing or swallowing, swelling of face, lips, tongue, throat, severe itching, red rash, raised bumps
• Common: infection (chills, increased temperature), coughing, wheezing, excessive thirst, high urine output or severely decreased urine output, tiredness, bleeding, increased appetite with weight loss

Word of Advice:

• Certican 0.25mg tablet can cause harm to the unborn fetus
• Inform your healthcare provider before starting this treatment if you are pregnant or planning for pregnancy
• Discuss effective birth control methods with your healthcare provider and use them during the treatment for 8 weeks after your last dose
• The occurrence of mouth ulcers or sores is common during this treatment, so your healthcare provider will prescribe a mouthwash

FAQs:

1. What you should know before taking Certican 0.25mg tablet? Before taking Certican 0.25mg tablet, it is important to know that your risk of getting bacterial or viral infection increases with this treatment. If you have been infected with Hepatitis B, this drug increases the chances of reinfection. Tell your healthcare provider if you experience fever, chills, cough, yellowing of the skin, joint pain, or swelling during this treatment.

2. Is it safe to use Certican 0.25mg tablet during pregnancy? Certican 0.25mg tablet have the tendency to cause harm to the unborn fetus. Inform your healthcare provider before starting this treatment if you are pregnant, or planning for pregnancy. Your healthcare provider will conduct a pregnancy test before you start treatment with this drug.

3. What are the side effects of Certican 0.25mg tablet? The common side effects that are likely to occur while you are on the treatment with Certican 0.25mg tablet are fever, chills, skin rash, joint pain, swelling, tiredness, loss of appetite, high risk of infection, mouth ulcers, and difficulty breathing.

4. Is it safe to undergo surgery while on treatment with Certican 0.25mg Tablet? Certican 0.25mg tablet may lead to poor wound healing ability. Consult your healthcare provider and stop taking this tablet at least one week before planned surgery.

5. Can I drink alcohol while taking Certican 0.25mg tablet? It is generally recommended to avoid drinking alcohol while taking Certican 0.25mg tablet, as alcohol can increase the risk of liver damage.

Fact Box:

• Molecule name: Everolimus
• Therapeutic class: Antineoplastics
• Pharmacological class: mTOR kinase inhibitors
• Indications:
  • Advanced breast cancer
  • Advanced renal cell carcinoma
  • Advanced pancreatic neuroendocrine tumours
  • Treatment of subependymal giant cell astrocytoma

Tags: Certican, immunosuppressant, drug, 0.25mg, tablet, medicine, medical-treatment